Skip to content
Taxonomy
2023 CMTA-STAR Celebrating our Collective Achievements
Significant Research Investment Made in 2023: We are excited to Read More
ToolGen CMT1A Treatment Receives Orphan Drug Designation
CMTA Alliance Partner ToolGen announced December 18, 2023 that it Read More
A Retrospective Study of Subjects with Mutations in the C12ORF65 Gene Causing Complex CMT Type 6
A Retrospective Study of Subjects with Mutations in the C12ORF65 Read More
Stanford Chronic Pain Study
Stanford Chronic Pain Study A Stanford research team needs feedback Read More
CMTA Appoints Katherine Forsey Chief Research Officer
(GLENOLDEN, Pa. – June 2, 2022) The Charcot-Marie-Tooth Association today Read More
Data Shows Benefit with PXT3003 in Patients with CMT1A
New Data from the Open-Label PLEO-CMT-FU Trial Shows Sustained Benefit Read More
Orphan Drug Designation for TSHA-120 for Treatment of GAN
Taysha Gene Therapies Receives Orphan Drug Designation from the European Read More
Participants Needed for SORD Clinical Trial
Participants Needed for SORD Clinical Trial Plans are underway for Read More
The CMTA Earns a Perfect Rating From Charity Navigator
The Charcot-Marie-Tooth Association Earns a Perfect Rating From Charity Navigator Read More
Finding Your CMT Gene
Finding Your CMT Gene – The Distant Cousin Project The Read More
